Oxford Biomedica plc

OTCPK:OXBD.F Stock Report

Market Cap: US$529.9m

Oxford Biomedica Management

Management criteria checks 2/4

Oxford Biomedica's CEO is Frank Mathias, appointed in Mar 2023, has a tenure of 1.5 years. total yearly compensation is £520.00K, comprised of 88.1% salary and 11.9% bonuses, including company stock and options. directly owns 0.019% of the company’s shares, worth $100.64K. The average tenure of the management team and the board of directors is 1 years and 3.5 years respectively.

Key information

Frank Mathias

Chief executive officer

UK£520.0k

Total compensation

CEO salary percentage88.1%
CEO tenure1.5yrs
CEO ownership0.02%
Management average tenure1yrs
Board average tenure3.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Frank Mathias's remuneration changed compared to Oxford Biomedica's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-UK£142m

Mar 31 2024n/an/a

-UK£150m

Dec 31 2023UK£520kUK£458k

-UK£157m

Compensation vs Market: Frank's total compensation ($USD696.67K) is below average for companies of similar size in the US market ($USD2.40M).

Compensation vs Earnings: Insufficient data to compare Frank's compensation with company performance.

CEO

Frank Mathias (62 yo)

1.5yrs

Tenure

UK£520,000

Compensation

Dr. Frank Mathias is Chief Executive Officer and Director of Oxford Biomedica plc from March 27, 2023. Dr. Mathias was the Chief Executive Officer of Rentschler Biopharma SE from April 2016 until March 202...

Leadership Team

NamePositionTenureCompensationOwnership
Frank Mathias
CEO & Director1.5yrsUK£520.00k0.019%
£ 100.6k
Lucinda Crabtree
CFO & Directorno datano datano data
Thierry Cournez
COO & Oxford Site Headless than a yearno datano data
Sophia Bolhassan
Head of Investor Relationsno datano datano data
Natalie Walter
General Counsel & Company Secretary5.3yrsno datano data
Lisa James
Chief People Officer2.4yrsno datano data
Kyriacos Mitrophanous
Chief Innovation Officerless than a yearno datano data
Kati Hudson
Head of Intellectual Property and Contractsno datano datano data
Sebastien Ribault
Chief Commercial Officer1.8yrsno datano data
Mark Caswell
Site Head of US Operations1.2yrsno datano data
Stephanie Colloud
Site Head & GM of France Operationsless than a yearno datano data
Sabine Sydow
Chief of Staffless than a yearno datano data

1.0yrs

Average Tenure

51yo

Average Age

Experienced Management: OXBD.F's management team is not considered experienced ( 1 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Frank Mathias
CEO & Director1.5yrsUK£520.00k0.019%
£ 100.6k
Lucinda Crabtree
CFO & Directorno datano datano data
Frederic Doliveux
Non-Executive Chair4.3yrsUK£225.00k0.35%
£ 1.9m
William Langston
Member of Scientific Advisory Boardno datano datano data
Peter Stern
Member of Scientific Advisory Boardno datano datano data
Krystof Bankiewicz
Member of Scientific Advisory Boardno datano datano data
Leone Patterson
Independent Non-Executive Director1.3yrsUK£87.00k0.012%
£ 62.6k
Heather Preston
Independent Non-Executive Director6.5yrsUK£140.00k0.017%
£ 92.1k
Dame Davies
Senior Independent Director3.5yrsUK£73.00k0.00095%
£ 5.0k
Stuart Henderson
Independent Vice Chair8.3yrsUK£85.00k0.010%
£ 54.6k
Robert Ghenchev
Non-Executive Director5.3yrsno datano data
Namrata Patel
Independent Non-Executive Director2.4yrsUK£65.00k0.0087%
£ 46.2k

3.5yrs

Average Tenure

62yo

Average Age

Experienced Board: OXBD.F's board of directors are considered experienced (3.5 years average tenure).